Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-300634
Filing Date
2025-11-26
Accepted
2025-11-26 16:29:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d36960d424b3.htm 424B3 135348
2 GRAPHIC g36960g40a89.jpg GRAPHIC 35653
  Complete submission text file 0001193125-25-300634.txt   185628
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-291269 | Film No.: 251530742
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)